🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The SchistoSAM study is an open label, two-arm, individually-randomized con...
Status
Completed
Location
Institut de Recherche en Santé, de Surveillance Épidémiologique et de Formation (IRESSEF)
Start Date
2019-10-14
Trial ID
NCT03893097
Treatments Being Tested
The purpose of the study is to understand whether the drug praziquantel (PZ...
Status
Completed
Location
Research Institute for Tropical Medicine - Health Compound
Start Date
2012-01
Trial ID
NCT01288872
Treatments Being Tested
The study would evaluate the safety and efficacy of L-praziquantel orodispe...
Status
Completed
Location
Universitè de Cocody
Start Date
2019-09-02
Trial ID
NCT03845140
Treatments Being Tested
Knowledge, acceptability and perception of paediatric schistosomiasis and i...
Status
Unknown
Location
Université Félix Houphouët-Boigny
Start Date
2021-12-01
Trial ID
NCT05350462
Treatments Being Tested
The purpose of this study is to determine if combination drug therapy of pr...
Status
Completed
Location
Hospital Nacional Edgardo Rebagliati
Start Date
2010-01
Trial ID
NCT00441285
Treatments Being Tested
Female genital schistosomiasis (FGS) is a frequent manifestation of the inf...
Status
Completed
Location
K'Olo Vanona
Start Date
2019-09-03
Trial ID
NCT04115072
Treatments Being Tested
The primary objective of the trial is to compare the "overall palatability"...
Status
Completed
Location
Ifakara Health Institute
Start Date
2015-04
Trial ID
NCT02315352
Treatments Being Tested
Objectives:To reduce the risk of S. haematobium pathology recurrences durin...
Status
Completed
Location
ESPOIR Pour La Santé
Start Date
2009-02
Trial ID
NCT00870649
Treatments Being Tested
This is a phase I, open-label, randomized, 5 period, crossover, single-cent...
Status
Completed
Location
Please contact the Merck KGaA Communication Center
Start Date
2014-10-31
Trial ID
NCT02271984
Treatments Being Tested
The Phase II study consisted of two parts, part 1 is open label, randomized...
Status
Completed
Location
Please Contact the Communication Center
Start Date
2016-06-12
Trial ID
NCT02806232